We are very sorry but it looks like you are using an outdated browser. We strongly recommend updating to a modern browser.
More information about your browser and how to update

Invivoscribe Technologies

Invivoscribe Technologies, Inc., is a privately-held corporation dedicated to improving the quality of healthcare worldwide by providing high quality, reliable, cutting-edge tools for molecular research, molecular diagnostics, and personalized molecular medicine.

Invivoscribe provides a comprehensive selection of PCR-based gene rearrangement, chromosome translocation, and gene mutation Research Use Only testing reagents and controls. We also provide CE-marked in vitro diagnostic products to customers outside North America, and our subsidiary. Customers include many of the world's leading pharmaceutical and biotechnology companies, medical centers, cancer research centers, reference laboratories and molecular testing centers.
 

Details


Address:
Invivoscribe Technologies

Bunsenstr. 7a
82152 Martinsried
Germany
Field of Activity:
Hospital & Medical Practice
Manufacturing
Research & Development
Sales
Expansion:
international
Number of employess:
51-500
Founding year:
1995